Condition: Pharyngitis Acute · Pharyngitis · Nasopharyngitis · Sponsor: Valenta Pharm JSC
This study aims to evaluete of tthe efficacy and safety of using different doses of the drug Grammidin with anesthetic, a metered dose topical spray, in the treatment of acute infectious and inflammatory pharyngeal diseases.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| State autonomous health care institution "Engels City Clinical Hospital No. 1" | Engel's, Russia | Recruiting |
| State Budgetary Healthcare Institution of the Kaliningrad Region "City Hospital No. 2." | Kaliningrad, Russia | Recruiting |
| Unimed-C Jsc | Moscow, Russia | Recruiting |
| Professors' Clinic LLC. | Perm, Russia | Recruiting |
| Limited Liability Company "Medical Center Eco-Safety" | Saint Petersburg, Russia | Recruiting |
| Aurora MedFort LLC | Saint Petersburg, Russia | Recruiting |
| St. Petersburg State Budgetary Healthcare Institution "City Polyclinic No. 117" | Saint Petersburg, Russia | Recruiting |
| Limited Liability Company "Clinic Zvezdnaya" | Saint Petersburg, Russia | Recruiting |
| Limited Liability Company "Meili" | Saint Petersburg, Russia | Recruiting |
| LLC "Mariel Clinic" | Saint Petersburg, Russia | Recruiting |
| LLC "Center for DNA Research" | Saratov, Russia | Recruiting |
| LLC "Polyclinic Polimedika Veliky Novgorod" | Veliky Novgorod, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06843018